TapImmune, Inc. to Present Progress on Clinical Trials for Cancer Vaccines

Chairman and CEO, Dr. Glynn Wilson, and COO, Dr John Bonfiglio, will speak with investors and advisors through an interactive real-time virtual conference on Thursday, February 2, 2017. During the webinar, Dr. Bonfiglio and Dr. Wilson will focus on the company’s recent accomplishments and progress, especially surrounding its sponsored Phase 2 trial in triple-negative breast cancer now…